Cargando…
Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity
Prader–Willi syndrome (PWS) represents the most common genetic-derived obesity disorder caused by the loss of expression of genes located on the paternal chromosome 15q11.2-q13. The PWS phenotype shows peculiar physical, endocrine and metabolic characteristics compared to those observed in non-syndr...
Autores principales: | Pascut, Devis, Tamini, Sofia, Bresolin, Silvia, Giraudi, Pablo, Basso, Giuseppe, Minocci, Alessandro, Tiribelli, Claudio, Grugni, Graziano, Sartorio, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240145/ https://www.ncbi.nlm.nih.gov/pubmed/30352401 http://dx.doi.org/10.1530/EC-18-0329 |
Ejemplares similares
-
Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader–Willi Syndrome and Non-Syndromic Obesity
por: Pratama, Muhammad Yogi, et al.
Publicado: (2020) -
Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome
por: Pascut, Devis, et al.
Publicado: (2023) -
Growth hormone therapy for Prader–willi syndrome: challenges and solutions
por: Grugni, Graziano, et al.
Publicado: (2016) -
Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome
por: Paolo, Marzullo, et al.
Publicado: (2020) -
Changes of Body Weight and Body Composition in Obese Patients with Prader–Willi Syndrome at 3 and 6 Years of Follow-Up: A Retrospective Cohort Study
por: Bedogni, Giorgio, et al.
Publicado: (2020)